The impact of obstructive sleep apnea (OSA) severity on type 2 diabetes prevalence

I. Bouloukaki (Heraklion, Greece), M. Markakis (Heraklion, Greece), R. Pateli (Heraklion, Greece), M. Fanaridis (Heraklion, Greece), G. Pitsiadianakis (Heraklion, Greece), G. Stathakis (Heraklion, Greece), N. Tzanakis (Heraklion, Greece), S. Schiza (Heraklion, Greece)

Source: Sleep and Breathing Conference 2021
Session: Sleep disorders and comorbidities: cardiopulmonary, cerebral and metabolic
Session type: Oral Presentation
Number: 0
Disease area: Sleep and breathing disorders

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Bouloukaki (Heraklion, Greece), M. Markakis (Heraklion, Greece), R. Pateli (Heraklion, Greece), M. Fanaridis (Heraklion, Greece), G. Pitsiadianakis (Heraklion, Greece), G. Stathakis (Heraklion, Greece), N. Tzanakis (Heraklion, Greece), S. Schiza (Heraklion, Greece). The impact of obstructive sleep apnea (OSA) severity on type 2 diabetes prevalence. Sleep and Breathing Conference 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of obstructive sleep apnoea in men with type 2 diabetes
Source: Eur Respir J 2005; 26: Suppl. 49, 567s
Year: 2005

The impact of smoking status on obstructive sleep apnea (OSA) severity.
Source: International Congress 2018 – Sleep and breathing control: phenotypes
Year: 2018

Influence of smoking on symptoms, comorbidities and severity in a population with obstructive sleep apnea (OSA) versus control
Source: Annual Congress 2011 - Epidemiology of smoking and smoking cessation interventions
Year: 2011


The prevalence of obstructive sleep apnea (OSA) in patients with severe asthma and the association between severity of OSA and asthma control
Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases
Year: 2020


Prevalence of cardiorespiratory disease increase with increasing severity of obstructive sleep apnoea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 322s
Year: 2002

Correlations between cardiovascular diseases and diabetes in obstructive sleep apnoea (OSA)
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Prevalence of stroke in obstructive sleep apnoea (OSA) patients
Source: Eur Respir J 2007; 30: Suppl. 51, 331s
Year: 2007

The relationship between obstructive sleep apnea hypopnea syndrome and insulin resistance, vascular complications in patients with type 2 diabetes mellitus
Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I
Year: 2011

Impact of obstructive sleep apnoea (OSA) on glucose metabolism
Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment
Year: 2007


Prevalence and predictors of arrhythmia in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011


Relationship between age and cardiovascular diseases (CVD) in obstructive sleep apnoea (OSA)
Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea
Year: 2008


Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Prevalence and predictors of obstructive sleep apnea (OSA) in a general Norwegian population
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010


Smoking (active and former) among factors influencing severity of both pathologies in a population with obstructive sleep apnea (OSA) and chronic obstructive bronhopneumopathy (COPD)
Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies
Year: 2010


Prevalence of nocturia in obstructive sleep apnoea (OSA)
Source: Eur Respir J 2006; 28: Suppl. 50, 646s
Year: 2006

The effect of concomitant COPD on obstructive sleep apnea syndrome severity and sleep structure
Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity
Year: 2011

Physical activity in obstructive sleep apnea (OSA) patients with high cardiovascular risk
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010


Increased rates of obstructive sleep apnea (OSA) in COVID-19-patients
Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19
Year: 2021


Frequency of metabolic syndrome (MS) in patients with obstructive sleep apnoea (OSA) depends on adopted definition
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010